[Form 4] Urgent.ly Inc. Insider Trading Activity
Urgent.ly Inc. (ULY) director Ben Volkow reported sales of common stock under a Rule 10b5-1 trading plan. The Form 4 shows two reported dispositions: 800 shares sold on 09/18/2025 at a weighted-average price of $3.7789 (individual trade prices ranged $3.75–$3.82) and 1,457 shares sold on 09/19/2025 at a weighted-average price of $4.0567 (individual trade prices ranged $3.79–$4.23).
Following these transactions the reporting person beneficially owned 12,136 shares. The filer discloses that the sales were executed pursuant to a 10b5-1 plan adopted on November 20, 2023, and offers to provide breakdowns of shares sold at each price upon request.
- Sales executed under a Rule 10b5-1 plan, indicating transactions were pre-planned and aimed to provide an affirmative defense to insider trading claims
- Transparent pricing disclosure: filing reports weighted-average prices and price ranges and offers to provide detailed breakdowns on request
- Reduction in beneficial ownership: the reporting person sold a total of 2,257 shares, leaving 12,136 shares beneficially owned following the transactions
Insights
TL;DR: Insider sales were executed under a pre-established 10b5-1 plan, indicating a rule-compliant disposal of shares.
The Form 4 clearly documents that the sales of 2,257 shares were made under a Rule 10b5-1 trading plan adopted on November 20, 2023. The filing provides weighted-average prices and ranges and offers to provide further breakdowns on request, which supports transparency. From a compliance perspective, the disclosure meets Section 16 reporting requirements and the 10b5-1 affirmative defense disclosure standard.
TL;DR: Director reduced holdings to 12,136 shares via small-volume sales across two days at ~$3.78–$4.06 average prices.
The total disposed amount of 2,257 shares is modest in absolute terms as presented; the filing does not provide context on percentage ownership or company market capitalization, so materiality to shareholders cannot be determined from this Form 4 alone. The precise weighted-average prices and disclosed ranges are useful for trade-level analysis but do not indicate company operational or financial performance.